EGFR-IN-49
EGFR-IN-49 is a potent and selective EGFR inhibitor with IC50s of 65.0 nM and 13.6 nM for EGFRT790M and EGFRT790M/L858R, respectively. EGFR-IN-49 induces late apoptosis in a dose-dependent manner[1].
Product Specifications
CAS Number
2459932-81-9
UNSPSC
12352005
Target
EGFR
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/egfr-in-49.html
Solubility
10 mM in DMSO
Smiles
C=CC(NC1=CC(OC2=NC(NC3=CC=CC(C#N)=C3)=NC4=C2SC=C4)=CC=C1)=O
Molecular Formula
C22H15N5O2S
Molecular Weight
413.45
References & Citations
[1]Xiao Z, et al. Design, synthesis and antitumor activity of novel thiophene-pyrimidine derivatives as EGFR inhibitors overcoming T790M and L858R/T790M mutations. Eur J Med Chem. 2020 Oct 1;203:112511.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
EGFR/ErbB1/HER1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
OR1074001-01 25 mg
3- (2- (2- ((2- (2,6-Dioxopiperidin-3-yl) -1,3-dioxoisoindolin-5-yl) amino) ethoxy) ethoxy) propanoic acid
Sign In for Pricing
View Details OR1074001-02 50 mg
3- (2- (2- ((2- (2,6-Dioxopiperidin-3-yl) -1,3-dioxoisoindolin-5-yl) amino) ethoxy) ethoxy) propanoic acid
Sign In for Pricing
View Details OR1074001-03 100 mg
3- (2- (2- ((2- (2,6-Dioxopiperidin-3-yl) -1,3-dioxoisoindolin-5-yl) amino) ethoxy) ethoxy) propanoic acid
Sign In for Pricing
View Details OR1074001-04 250 mg
3- (2- (2- ((2- (2,6-Dioxopiperidin-3-yl) -1,3-dioxoisoindolin-5-yl) amino) ethoxy) ethoxy) propanoic acid
Sign In for Pricing
View Details OR1074001-05 1 g
3- (2- (2- ((2- (2,6-Dioxopiperidin-3-yl) -1,3-dioxoisoindolin-5-yl) amino) ethoxy) ethoxy) propanoic acid
Sign In for Pricing
View Details 
MBS7230051-01 48 Well
Bovine cadherln-related neuronal receptor1, CNR-1 ELISA Kit
Sign In for Pricing
View Details